Pembrolizumab in Treating Patients With Small Bowel Adenocarcinoma That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery

Clinical trial NCT02949219 · UNKNOWN

Trial details

NCT number: NCT02949219
Sponsor: Academic and Community Cancer Research United
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Small Intestinal Adenocarcinoma Recurrent Small Intestinal Carcinoma Unresectable Small Intestinal Carcinoma

Start date: 2017-03-24
Primary completion: 2019-01-31
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.